wegovy shortage - Search News

Ozempic, Wegovy

Wegovy, Ozempic shortage declared over, hitting copycats like Hims & Hers

The ruling shows Novo Nordisk’s confidence that the supply of semaglutide will be stable for now.

Hosted on MSN · 18h

Ozempic and Wegovy shortage ends, setting up weight loss drug showdown

Ozempic and Wegovy, the popular GLP-1 drugs for diabetes and weight loss, are no longer in short supply, the FDA declared Friday. Why it matters: That's good news for Novo Nordisk (whose stock rose 5% Friday) and potentially bad news for Hims & Hers (which fell 26%).

MarketWatch · 1d

FDA says Ozempic and Wegovy shortage is ending. That’s bad news for this wellness stock.

We will continue to offer access to personalized treatments as allowed by law to meet patient needs,” Hims & Hers CEO said.

22hon MSN

Generic Wegovy, Ozempic compounds may become harder to get as FDA removes drug from shortage list

Compounding pharmacies producing cheaper semaglutide products have been given notice they will soon have to stop, as the drug ...

BioPharma Dive1d

Ozempic, Wegovy shortage resolved; Pfizer CEO is PhRMA’s new chair

The FDA determined that Novo Nordisk’s obesity and diabetes drugs are no longer in short supply. Elsewhere, Concentra made a ...

Dozens of attorneys general urge FDA to crack down on counterfeit obesity drugs

More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.

2d

Why Novo Nordisk Is A Strong Buy Despite Market Concerns

Novo Nordisk thrives despite competition and explore its breakthrough amycretin study. Read here to know why we rate NVO ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results